Hyundai Bioscience presented the results of its Penetrium™ combination preclinical studies at the 2025 American Association ...

OmRx Oncology, or "OmRx," a clinical-stage biopharmaceutical venture dedicated to expanding access to cancer immunotherapy worldwide, today announced the initiation of a Phase 2 clinical trial of its ...

The RAPID-RT study introduced a heart-sparing technique in radiotherapy for lung cancer, showing improvement in survival by ...

A new study presented at ESTRO 2025 introduces the RAPID-RT study, which uses an innovative rapid-learning approach to ...

News: AstraZeneca and Qure.ai complete 5M AI-powered chest scans, enhancing early lung cancer detection across 20+ countries ...

A new study presented at ESTRO 2025 introduces the RAPID-RT study, which uses an innovative rapid-learning approach to ...

Responsible AI necessitates explainability to foster trust and enable informed decisions. Opaque AI models, particularly ...

PRNewswire/ - Geneseeq Technology Inc., in collaboration with leading clinical institutions, has developed a cutting-edge blood-based screening test that could transform early detection of pancreatic ...

Updated daily for the most current view of patient care, Truveta Data accelerates evidence generation by replacing costly ...

The escalating burden of lung, breast, and gastric cancers across Asia presents a pressing public health challenge, compounded by the region’s vast ...